STAAR Surgical Company (STAA: Quote), a maker of implantable lenses and delivery systems for the eye, Monday said it received the regulatory nod to market its Visian Implantable Collamer Lens or ICL with CentraFlow technology, in India.
The company said the approval from CDSCO will help expand its market in India where there has been a 48% compound annual growth rate for the Visian ICL, over the last four years.
Don Todd, President of the Asia Pacific Region for STAAR Surgical said, "Our marketing partner, Spica Medical, has seen a lot of anticipation in the market for the CentraFLOW technology as inquiries from surgeons and clinics over the past few weeks have been tremendous. With this approval in India, we can now leverage this growing acceptance to further penetrate a significantly large market."
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org